Inventor
FAROKHZAD OMID C
US57 patents
⚠️ This page may combine multiple inventors who share the name “FAROKHZAD OMID C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MASSACHUSETTS INST TECHNOLOGY
17 patentsUS9474717B2Oct 25, 2016
Vaccine nanotechnology
MASSACHUSETTS INST TECHNOLOGY33 citations97
US9439859B2Sep 13, 2016
Adjuvant incorporation in immunoanotherapeutics
MASSACHUSETTS INST TECHNOLOGY34 citations97
US9308280B2Apr 12, 2016
Targeting of antigen presenting cells with immunonanotherapeutics
MASSACHUSETTS INST TECHNOLOGY45 citations97
US8367113B2Feb 5, 2013
Polymers for functional particles
MASSACHUSETTS INST TECHNOLOGY56 citations97
US8343498B2Jan 1, 2013
Adjuvant incorporation in immunonanotherapeutics
MASSACHUSETTS INST TECHNOLOGY51 citations97
US7727969B2Jun 1, 2010
Controlled release nanoparticle having bound oligonucleotide for targeted delivery
MASSACHUSETTS INST TECHNOLOGY113 citations97
US7550441B2Jun 23, 2009
Controlled release polymer nanoparticle containing bound nucleic acid ligand for targeting
MASSACHUSETTS INST TECHNOLOGY160 citations97
US9233072B2Jan 12, 2016
Adjuvant incorporation in immunonanotherapeutics
MASSACHUSETTS INST TECHNOLOGY27 citations94
US8802153B2Aug 12, 2014
System for targeted delivery of therapeutic agents
MASSACHUSETTS INST TECHNOLOGY37 citations94
US9539210B2Jan 10, 2017
Vaccine nanotechnology
MASSACHUSETTS INST TECHNOLOGY27 citations93
US9526702B2Dec 27, 2016
Vaccine nanotechnology
MASSACHUSETTS INST TECHNOLOGY4 citations83
US9080014B2Jul 14, 2015
Polymers for functional particles
MASSACHUSETTS INST TECHNOLOGY5 citations83
US11547667B2Jan 10, 2023
Vaccine nanotechnology
MASSACHUSETTS INST TECHNOLOGY1 citations72
US9649391B2May 16, 2017
Particles with multiple functionalized surface domains
MASSACHUSETTS INST TECHNOLOGY4 citations70
US8906417B2Dec 9, 2014
Nanostructures for drug delivery
MASSACHUSETTS INST TECHNOLOGY4 citations70
US10864162B2Dec 15, 2020
Mass production and size control of nanoparticles through controlled microvortices
MASSACHUSETTS INST TECHNOLOGY6 citations67
US9688812B2Jun 27, 2017
Polymers for functional particles
MASSACHUSETTS INST TECHNOLOGY0 citations51
BRIGHAM & WOMENS HOSPITAL INC
12 patentsUS10866242B2Dec 15, 2020
System and method for protein corona sensor array for early detection of diseases
BRIGHAM & WOMENS HOSPITAL INC30 citations93
US10201655B2Feb 12, 2019
Methods and devices for inserting a needle
BRIGHAM & WOMENS HOSPITAL INC2 citations72
US10675351B2Jun 9, 2020
Nanostructured gels capable of controlled release of encapsulated agents
BRIGHAM & WOMENS HOSPITAL INC1 citations69
US9974859B2May 22, 2018
Nanostructured gels capable of controlled release of entrapped agents
BRIGHAM & WOMENS HOSPITAL INC3 citations69
US10272050B2Apr 30, 2019
Nanoparticles and methods of use
BRIGHAM & WOMENS HOSPITAL INC6 citations68
US11090367B2Aug 17, 2021
Restoration of tumor suppression using mRNA-based delivery system
BRIGHAM & WOMENS HOSPITAL INC2 citations67
US11123304B2Sep 21, 2021
Nanoparticles having poly(ester amide) polymer cores as drug delivery vehicles
BRIGHAM & WOMENS HOSPITAL INC1 citations62
US11672864B2Jun 13, 2023
Nanostructured gels capable of controlled release of encapsulated agents
BRIGHAM & WOMENS HOSPITAL INC0 citations59
US10583091B2Mar 10, 2020
Amphiphile-polymer particles
BRIGHAM & WOMENS HOSPITAL INC1 citations59
US11833255B2Dec 5, 2023
Nanoparticles with pH triggered drug release
BRIGHAM & WOMENS HOSPITAL INC0 citations57
US11471515B2Oct 18, 2022
Restoration of tumor suppression using MRNA-based delivery system
BRIGHAM & WOMENS HOSPITAL INC0 citations56
US9931477B2Apr 3, 2018
Methods and devices for sensing tissues and tissue compartments
BRIGHAM & WOMENS HOSPITAL INC0 citations51
IANNACONE MATTEO
3 patentsUS8277812B2Oct 2, 2012
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
IANNACONE MATTEO45 citations97
US8932595B2Jan 13, 2015
Nicotine immunonanotherapeutics
IANNACONE MATTEO33 citations93
US8906381B2Dec 9, 2014
Immunonanotherapeutics that provide IGG humoral response without T-cell antigen
IANNACONE MATTEO31 citations92
FAROKHZAD OMID C
2 patentsSHI JINJUN
2 patentsPROGNOMIQ INC
2 patentsBRIGHAM & WOMENS HOSPITAL
1 patentALEXIS FRANK
1 patentGU FRANK X
1 patentVON ANDRIAN ULRICH
1 patentSLOCUM ALEXANDER
1 patentRADOVIC-MORENO ALEKSANDAR F
1 patentVON ANDRIAN ULRICH H
1 patentZHANG LIANGFANG
1 patentRADOVIC-MORENO ALEKSANDAR FILIP
1 patentKARNIK ROHIT
1 patentLIPPARD STEPHEN J
1 patentHARVARD COLLEGE
1 patentShowing the top 50 of 57 patents by PatentIndex Score.